secwatch.observer — SEC 8-K summary
======================================

Issuer:     HALOZYME THERAPEUTICS, INC. (HALO)
CIK:        0001159036
Form:       8-K
Filed at:   2023-05-08T23:59:59+00:00
Accession:  0001159036-23-000033
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Halozyme stockholders elect three Class I directors and approve 2023 auditor at annual meeting
--------------------------------------------------------------------------------

- All three Class I director nominees elected: Connaughton, Miyashita, Posard, with majority votes.
- Advisory vote on executive compensation approved with 107.6M for vs 4.7M against (95.8% support).
- Stockholders chose annual frequency for future advisory votes on executive compensation (110.4M for one year).
- Ratification of Ernst & Young as auditor for FY2023 approved with 123.3M votes for (98.8% of votes cast).
- Turnout: 124.5M shares represented out of 135.4M outstanding (92% attendance).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1159036/000115903623000033/0001159036-23-000033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1159036/000115903623000033/halo-20230505.htm
  HTML page:      https://secwatch.observer/filing/0001159036-23-000033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer